Senior Equity Research Analyst at Zacks Investment Management
Brad Sorensen, CFA is a Senior Equity Research Analyst at Zacks Small-Cap Research, specializing in small-cap equities across a range of market sectors. He has provided analysis and coverage on specific companies such as Scilex Holding, and his research has supported investment decisions for a wide audience of institutional and individual investors; while his exact performance metrics are confidential, his reports and recommendations are widely circulated and respected in the field. Sorensen began his career over twenty years ago, previously serving as Managing Director of Market and Sector Analysis and Director of Sector Analysis at Charles Schwab before joining Zacks in 2021. He holds both an MBA and MS in Finance from the University of Colorado and maintains the prestigious Chartered Financial Analyst (CFA) designation.
Inquired about other potential partnership opportunities beyond the one mentioned in Europe and asked for any developments on securing additional government funding.
D. Kirkpatrick responded that they are continuing discussions with OncoZenge and are also exploring opportunities for their more developed opioid products with other groups. The company is also actively exploring additional funding opportunities through the NIH HEAL program.
Brad Sorensen from Zacks asked for an update on the company's acquisition strategy, questioning if the focus is on new acquisitions or integrating existing ones.
CEO Roger Hamilton stated that while acquisitions remain part of the strategy, the immediate focus is on integrating current companies to achieve positive EBITDA and prove out synergies, given the shift in market conditions. He outlined a future 'three-pronged' growth approach: organic growth, partner growth, and strategic acquisitions. Hamilton also noted a new interest in acquiring EdTech companies, which have become more attractively priced, in addition to their historical focus on education-content companies. He emphasized that most acquisitions, like Revealed Films, begin as partners on the GeniusU platform.
Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.
Trusted by leading investment firms and analysts